Trials / Terminated
TerminatedNCT03976596
Measurement of in Vivo Mitochondrial Capacity in Infants
Measurement of in Vivo Mitochondrial Capacity in Infants: a 31P-MRS Pilot Study
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (actual)
- Sponsor
- Pennington Biomedical Research Center · Academic / Other
- Sex
- All
- Age
- 14 Days – 28 Days
- Healthy volunteers
- Accepted
Summary
The overarching aim of this project is to determine the test re-test reliability of 31P-magnetic resonance spectroscopy measurements in infants. Primary endpoints include two separate measures of in vivo mitochondrial capacity (ATPmax) over a 1-10 day period to assess feasibility and reliability.
Conditions
Timeline
- Start date
- 2019-05-21
- Primary completion
- 2019-07-02
- Completion
- 2019-07-02
- First posted
- 2019-06-06
- Last updated
- 2026-02-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03976596. Inclusion in this directory is not an endorsement.